Tag: Pfizer
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera Emerges as the Hottest Contender in the Obesity Drug Market Metsera, a New York-based biotech company, has…
Pfizer (PFE): A Healthcare Giant Offering Steady Dividend Income
Pfizer Inc. (NYSE:PFE) is featured among the 10 Highest Dividend-Paying Stocks to Invest in the S&P 500. Pfizer…
Pfizer Agrees to Cut Drug Prices—What to Know
This article was originally published by The Epoch Times: Pfizer Agrees to Cut Drug Prices—What to Know In…
Pfizer Inc. (PFE): A Bull Case Theory
Recently, we encountered a bullish analysis on Pfizer Inc. on the Investing With Purpose Substack. This article aims…
Pfizer shares rise 3% after upping profit forecast for 2025
Pfizer, one of the leading pharmaceutical companies, has defied the odds with a strong performance in the second…
Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact
The major stock indexes closed the week with losses on Friday following a flurry of market-moving events. Earnings…
FDA asks Moderna, Pfizer to expand Covid vaccine risk label
The Food and Drug Administration (FDA) has recently requested Moderna and Pfizer/BioNTech, the manufacturers of mRNA Covid-19 vaccines,…
ASH 2024: Withdrawal of Pfizer sickle cell drug called ‘tone deaf’
SAN DIEGO — The recent withdrawal of Pfizer's sickle cell drug Oxybryta has sparked outrage among sickle cell…
Activist Starboard Value Takes $1 Billion Stake in Pfizer
Activist investor Starboard Value has recently made a significant move by taking a stake of approximately $1 billion…
Sickle cell community scrambles after a Pfizer drug is pulled from the market
Nana-Bilkisu Habib knew the feeling of pain all too well, but the experience she had last January was…
Pfizer decision to withdrawal sickle cell drug leaves patients, advocates reeling
Pfizer’s recent decision to withdraw its sickle cell pill, Oxbryta, from the market due to safety concerns has…